Droplet-based microfluidics in drug discovery, transcriptomics and high-throughput molecular genetics

Christoph Merten
2016
Journal paper

Abstract

Droplet-based microfluidics enables assays to be carried out at very high throughput (up to thousands of samples per second) and enables researchers to work with very limited material, such as primary cells, patient's biopsies or expensive reagents. An additional strength of the technology is the possibility to perform large-scale genotypic or phenotypic screens at the single-cell level. Here we critically review the latest developments in antibody screening, drug discovery and highly multiplexed genomic applications such as targeted genetic workflows, single-cell RNAseq and single-cell ChIPseq. Starting with a comprehensive introduction for non-experts, we pinpoint current limitations, analyze how they might be overcome and give an outlook on exciting future applications.

Official source

https://infoscience.epfl.ch/record/274638?ln=en

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related concepts

Related publications

Functional single-cell hybridoma screening using droplet-based microfluidics

Christoph Merten

Monoclonal antibodies can specifically bind or even inhibit drug targets and have hence become the fastest growing class of human therapeutics. Although they can be screened for binding affinities at very high throughput using systems such as phage display, screening for functional properties (e.g., the inhibition of a drug target) is much more challenging. Typically these screens require the generation of immortalized hybridoma cells, as well as clonal expansion in microtiter plates over several weeks, and the number of clones that can be assayed is typically no more than a few thousand. We present here a microfluidic platform allowing the functional screening of up to 300,000 individual hybridoma cell clones within less than a day. This approach should also be applicable to nonimmortalized primary B-cells, as no cell proliferation is required: Individual cells are encapsulated into aqueous microdroplets and assayed directly for the release of antibodies inhibiting a drug target based on fluorescence. We used this system to perform a model screen for antibodies that inhibit angiotensin converting enzyme 1, a target for hypertension and congestive heart failure drugs. When cells expressing these antibodies were spiked into an unrelated hybridoma cell population in a ratio of 1∶10,000 we observed a 9,400-fold enrichment after fluorescence activated droplet sorting. A wide variance in antibody expression levels at the single-cell level within a single hybridoma line was observed and high expressors could be successfully sorted and recultivated.

2012

Microfluidics and microtechnologies are of great interest for biological applications. This interest is linked to the fact that microtechnologies enable the study of single cells at the cellular and sub-cellular level. One of many applications of such single cell assays is cell-cell interaction probing. Current cell-cell interaction tools used by biologists rely on manual cell manipulation. But in the last decade new microfluidic technologies have arisen to tackle this biological challenge. Despite this growing need, the developped microfluidic devices still force biologists to compromise between the throughput of the assay (number of cell pairs interrogated) and the control over the interaction parameters (contact force and contact time). This thesis proposes an engineering point of view of microfluidic tools for single cell and in particular cell-cell interaction studies. The developed microfluidic devices enable an advancement of the microfluidic technologies to leverage new tools for cell-cell interaction interrogation in a controlled manner and at a high throughput. In this work we report the development of a novel microfluidic device based on a “roll-over” mechanism. This new chip design enables the multiplexing of cell-cell interactions. This multiplexing is achieved by forcing into contact all cells from a sample of a first cell population with all cells from a sample of a second cell population. Using such a device, we characterized the interaction of cells expressing olfactory receptors. This chip enables the maximization of cell-cell interaction interrogation and thus is ideally suited for rare and nonredundant cell populations. A droplet microfluidic chip for controlled and reliable cell co-encapsulation was designed and implemented. Common droplet microfluidic devices rely either on random cell co-encapsulation in droplets, thus leading to high cell loss, or use multiple microfluidic devices sequentially to perform droplet manipulation steps and achieve cell co-encapsulation. Both cases lead to cell sample loss, first from the random cell co-encapsulation process and second from the possible droplet loss between different microfluidic devices. Therefore, the implementation of a single fully integrated device enabling controlled cell co-encapsulation in droplets is of high interest for the study of precious, large cell libraries interactions for example in the case of cancer immunotherapy. In this thesis we also developed new concepts, using already existing microfluidic designs. By reusing the microfabrication technologies and microfluidic principles of the previously designed devices we could develop a novel microfluidic chip for another biological application. The third device studied in this thesis enables to look further into cell membrane receptors by isolating plasma membrane fragments. This tool enables an in-depth study of receptors involved in cell-cell interactions. It can also be used for any other cell membrane receptor study as for example G protein coupled receptor screening for therapeutic drug discovery. The tools developed in this thesis set the grounds for the development of new generations of cell-cell interaction microfluidic devices, enabling high throughput and control over the cell-cell interaction parameters. The technological advancements presented in this work were validated for various biological applications.

EPFL2020

Droplet-Based Microfluidic Platforms for the Encapsulation and Screening of Mammalian Cells and Multicellular Organisms

Christoph Merten

High-throughput, cell-based assays require small sample volumes to reduce assay costs and to allow for rapid sample manipulation. However, further miniaturization of conventional microtiter plate technology is problematic due to evaporation and capillary action. To overcome these limitations, we describe droplet-based microfluidic platforms in which cells are grown in aqueous microcompartments separated by an inert perfluorocarbon carrier oil. Synthesis of biocompatible surfactants and identification of gas-permeable storage systems allowed human cells, and even a multicellular organism (C. elegans), to survive and proliferate within the microcompartments for several days. Microcompartments containing single cells could be reinjected into a microfluidic device after incubation to measure expression of a reporter gene. This should open the way for high-throughput, cell-based screening that can use >1000-fold smaller assay volumes and has approximately 500x higher throughput than conventional microtiter plate assays.

2008

EPFL2020